Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2007-11-06
2007-11-06
Chen, Stacy B. (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C424S188100, C435S005000
Reexamination Certificate
active
10909310
ABSTRACT:
The peptide in this invention is a peptide having affinity to gp120 represented by Formula (1): H-A1-A2-A3-A4-A5-R(SEQ ID No. 1)(in the formula,H means hydrogen,A1 is aspartic acid, lysine, valine, glutamic acid, glycine, asparagine, or tyrosine residue,A2 is valine, aspartic acid, tryptophan, lysine, phenylalanine, isoleucine,leucine, or tyrosine residue,A3 is lysine, valine, aspartic acid, arginine, alanine, or tryptophan residue,A4 is alanine, tryptophan, or glycine residue,A5 is glycine, alanine, valine, leucine, isoleucine, serine, threonine, methionine, asparagine, glutamine, histidine, lysine, arginine, phenylalanine, tryptophan, proline, or tyrosine residue,R is OH derived from carboxyl group or NH2derived from acid amide group).The above peptide has an affinity to gp120 of the HIV envelope protein and is superior in stability.
REFERENCES:
patent: 6503729 (2003-01-01), Bult et al.
patent: 10-182695 (1998-07-01), None
patent: 10-182696 (1998-07-01), None
Fujii Takeru
Hamamoto Hidetoshi
Yokoyama Hideakira
Aspion Co., Ltd.
Chen Stacy B.
LandOfFree
Peptide having an affinity for gp120 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptide having an affinity for gp120, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide having an affinity for gp120 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3825758